News & Updates

Show Multimedia Only

Childhood-onset SLE a burden on academic achievement, employment in adult life

02 Jul 2021

Childhood-onset systemic lupus erythematosus (cSLE) has been shown to have a considerable impact on academic achievements and employment despite patients adjusting their educational and vocational choices, reveals a study.

Childhood-onset SLE a burden on academic achievement, employment in adult life

02 Jul 2021

Serum uric acid control helps prevent gout flare in asymptomatic hyperuricaemia, gout

01 Jul 2021

Patients with asymptomatic uricaemia or gout may do well to keep their serum uric acid levels below 6.0 mg/dL, which has been shown to minimize the occurrences of gout flare in a recent study.

Serum uric acid control helps prevent gout flare in asymptomatic hyperuricaemia, gout

01 Jul 2021

Plant-based protein diet lowers serum urate in gout patients

29 Jun 2021

A Dietary Approaches to Stop Hypertension (DASH)-style diet with an emphasis on plant-based protein reduces serum urate relative to that rich in carbohydrates or unsaturated fat, reports a recent study.

Plant-based protein diet lowers serum urate in gout patients

29 Jun 2021

Gout, hyperuricaemia do not influence dementia risk

28 Jun 2021 by

There is no clear evidence that gout and hyperuricaemia contribute to a heightened risk of dementia, although both conditions may be protective against Alzheimer’s disease, as shown in a study.

Gout, hyperuricaemia do not influence dementia risk

28 Jun 2021

Upadacitinib may benefit patients with PsA

25 Jun 2021 by

The oral Janus kinase inhibitor upadacitinib – which has gained approval for the treatment of rheumatoid arthritis (RA) – showed potential for treating individuals with psoriatic arthritis (PsA) who have insufficient response to nonbiologic disease-modifying antirheumatic drugs, according to the phase III SELECT-PsA 1 trial.

Upadacitinib may benefit patients with PsA

25 Jun 2021

Fitness level low in axial spondyloarthritis patients

25 Jun 2021

Patients with axial spondyloarthritis (AxSpA) have decreased exercise capacity, with low heart rate recovery tied to elevated 10-year risk of cardiovascular (CV) events, as reported in a study.

Fitness level low in axial spondyloarthritis patients

25 Jun 2021

Apremilast improves Behçet’s syndrome-related oral ulcers in both sexes

24 Jun 2021 by

The use of apremilast consistently reduced the number and pain due to oral ulcers in both men and women with active Behçet’s syndrome, according to a subgroup analysis of the RELIEF* study presented at EULAR 2021.

Apremilast improves Behçet’s syndrome-related oral ulcers in both sexes

24 Jun 2021

TNFi treatment in rheumatic disease not a risk for COVID-19 hospitalization

23 Jun 2021 by

Analysis of the German COVID-19 registry suggests that patients with rheumatic or musculoskeletal diseases (RMDs) who are treated with tumour necrosis factor (TNF) inhibitors appear to be at lower risk of severe outcomes of COVID-19 compared with those treated with other (non-TNF inhibitor) immunomodulatory treatments (OIDs).

TNFi treatment in rheumatic disease not a risk for COVID-19 hospitalization

23 Jun 2021

News & Updates

Showing Rheumatology articles

Showing

Specialty:

Childhood-onset SLE a burden on academic achievement, employment in adult life

Childhood-onset SLE a burden on academic achievement, employment in adult life

Serum uric acid control helps prevent gout flare in asymptomatic hyperuricaemia, gout

Serum uric acid control helps prevent gout flare in asymptomatic hyperuricaemia, gout

Plant-based protein diet lowers serum urate in gout patients

Plant-based protein diet lowers serum urate in gout patients

Gout, hyperuricaemia do not influence dementia risk

Gout, hyperuricaemia do not influence dementia risk

Upadacitinib may benefit patients with PsA

Upadacitinib may benefit patients with PsA

Fitness level low in axial spondyloarthritis patients

Fitness level low in axial spondyloarthritis patients

Apremilast improves Behçet’s syndrome-related oral ulcers in both sexes

Apremilast improves Behçet’s syndrome-related oral ulcers in both sexes

TNFi treatment in rheumatic disease not a risk for COVID-19 hospitalization

TNFi treatment in rheumatic disease not a risk for COVID-19 hospitalization